Press Releases

Latest Solution Provides Physicians with a Fast and Efficient Way to Query Their Patient Databases to Determine Potential Candidates for Clinical Studies and Automation and Elimination of Redundant Data Entry During Clinical Studies

March 31, 2009, Carrollton, Ga. – Greenway Medical Technologies Inc. has begun offering its state-of-the-art research solution, PrimeResearch^®, to physicians as part of its integrated electronic health record (EHR), practice management and interoperability solution, PrimeSuite^®. Further adding to a complete physician's infrastructure, PrimeResearch provides access to a vast network of clinical research; quality and safety initiatives; and composite (clinical and financial) analytics that can lead to more efficient processes, improved patient care and increased practice revenue.

PrimeResearch utilizes the Retrieve Form for Data Capture (RFD) Integrating the Healthcare Enterprise (IHE) profile that allows PrimeSuite users conducting clinical studies via PrimeResearch to retrieve eCRFs (Electronic Case Report Form) from any EDC (Electronic Data Capture) vendor. PrimeResearch is currently conducting such retrieval in conjunction with Outcome Sciences and NexTrials. Using RFD, PrimeSuite sends pre-filled data in a CCD-standard format that the EDC vendor then uses to pre-fill the eCRF. Once the form is surfaced within PrimeSuite, the user can fill in the remaining fields and submit the form back to the EDC vendor. In these real world studies, Greenway has seen as high as 90 percent pre-fill.

RFD was developed through a joint effort between the IHE and the Clinical Data Interchange Standards Consortium (CDISC), which operate to advance the continued improvement of public health by enabling efficiencies in medical research and related healthcare areas. Along with expanding the use of EHRs to clinical research, the RFD model also reduces duplicate data entry and improves data integrity, which can save a practice considerable time and money.

A key benefit of PrimeResearch is that it is designed to sync with the general workflow of a practice. Using RFD, PrimeSuite retrieves the form within the application and the user does not have to go to a separate system to re-enter the clinical study data.

Professional Park Medical Services of Carrollton, Georgia incorporated PrimeResearch into its daily workflow in 2008 after successfully streamlining its clinical, financial and administrative workflows through its adoption of the PrimeSuite EHR solution in 2005. The research functionality gained through PrimeResearch has enabled Professional Park to seamlessly incorporate participation in clinical studies made available through Outcome Sciences into daily workflows.

“PrimeResearch provides our practice with a state-of-the-art research tool that enables us to practice better medicine through participation in the clinical studies currently being conducted,” said Sebastian Mason, practice manager of Professional Park. “It was imperative that our research solution did not interrupt or hinder our ability to work efficiently and effectively. The benefit of PrimeResearch is that it syncs perfectly with our daily workflow while helping to improve the quality of care our physicians can offer.”

Another benefit of using the PrimeResearch solution is the automation of the patient identification and enrollment process before a study ever begins. Given the inclusion/exclusion criteria of a clinical study, PrimeSuite users can analyze the data that is returned from PrimeResearch to determine viable candidates within their PrimeSuite EHR solutions that meet such inclusion/exclusion criteria of the clinical study. In the past, finding patients to participate in clinical trials proved to be a cumbersome process, requiring a considerable investment of time and capital. PrimeResearch saves time and can now ensure that only qualified patients are identified as a result of the data captured in a practice's PrimeSuite application.

Pharmaceutical companies consistently rank patient enrollment as the number one reason for study delays and, on the other hand, patient advocacy groups are constantly stating patients cannot find studies.

“The process of digging through hundreds upon thousands of paper-based medical records to find one viable candidate for a clinical study is one of the primary reasons drug companies are unable to more quickly bring beneficial drugs to the market,” said Tee Green, president of Greenway Medical. “The cure for countless diseases exists within the confines of paper-based records but there is no way to effectively extract this information. PrimeResearch enables physicians to search through millions of medical records, electronically, in the time it takes a person to search through one.”

About Greenway Medical Technologies Inc.

Greenway Medical Technologies provides the latest in ambulatory healthcare business solutions and services to more than 23,500 healthcare providers and professionals nationwide, in 30 specialties and subspecialties, by enhancing the delivery of patient care through innovative HIT software and on-demand services that allow physician practices to function at their highest level of efficiency. Greenway's PrimeSuite is a comprehensive, interoperable component of the integrated physician's infrastructure solution, which serves as the starting point of a long-term business plan for physician practices. PrimeSuite 2008 is certified by CCHIT^® based on 08 Ambulatory EHR certification requirements. PrimeSuite integrates a practice's clinical, financial and administrative processes, and allows practices to increase profitability, enhance patient satisfaction and facilitate adherence to compliance guidelines. Established in 1998, Carrollton, Ga.-based Greenway Medical Technologies is a privately held company with approximately 300 employees. For more information about Greenway, visit http://www.greenwaymedical.com/.

Except for the historical information contained herein, the matters discussed in the press release are forward-looking statements within the meaning of the safe-harbor provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are subject to risks and uncertainties that may cause actual results to differ materially, including but not limited to economic, competitive, governmental, and technological factors affecting the Company's operations, markets, services and related products, prices, and other factors.